メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer

  • Takeshi Ogura
  • , Masahiro Tajika
  • , Yasumasa Niwa
  • , Hiroki Kawai
  • , Shinya Kondo
  • , Akira Sawaki
  • , Nobumasa Mizuno
  • , Kazuo Hara
  • , Susumu Hijioka
  • , Masamichi Nakamura
  • , Kazuhide Higuchi
  • , Hidemi Goto
  • , Kenji Yamao

研究成果: ジャーナルへの寄稿学術論文査読

抄録

We describe a 54-year old woman with oxaliplatin-induced autoimmune hemolytic anemia and review the clinical features of similar published cases. The present patient had metastatic colon cancer and was admitted to our hospital with a floating sensation and general malaise on day 4 after undergoing the last of 4 cycles of a 7 th round of chemotherapy with XELOX. Laboratory data revealed 4.6g/d/ hemoglobin and 8.77 mg/d/ creatinine. Direct and indirect Coombs tests of a blood sample for blood transfusion were both positive. We diagnosed immune hemolysis with acute renal failure based on the clinical course and blood samples showing haptoglobin <10mg/d/. We treated her with hemodialysis, plasmapheresis and immune suppression with prednisolone, which improved the anemia and renal failure.

本文言語英語
ページ(範囲)1712-1719
ページ数8
ジャーナルJournal of Japanese Society of Gastroenterology
108
10
出版ステータス出版済み - 10-2011

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 消化器病学

フィンガープリント

「Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル